pentylenetetrazole has been researched along with fluorescein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahishali, B; Arican, N; Bilgic, B; Ekizoglu, O; Elmas, I; Gurses, C; Kalayci, R; Karadeniz, A; Kaya, M; Kemikler, G; Kucuk, M; Orhan, N; Ustek, D | 1 |
1 other study(ies) available for pentylenetetrazole and fluorescein
| Article | Year |
|---|---|
Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Capillary Permeability; Endothelium; Fluorescein; Glial Fibrillary Acidic Protein; Levetiracetam; Malformations of Cortical Development; Membrane Proteins; Occludin; Pentylenetetrazole; Pinocytosis; Piracetam; Proto-Oncogene Proteins c-fos; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Tight Junctions | 2009 |